152 related articles for article (PubMed ID: 28084712)
1. Umeclidinium (Incruse Ellipta) for COPD.
Durigan RC; Niedermier V
Am Fam Physician; 2017 Jan; 95(2):120-121. PubMed ID: 28084712
[No Abstract] [Full Text] [Related]
2. Umeclidinium (Incruse Ellipta) for COPD.
Med Lett Drugs Ther; 2015 Apr; 57(1467):63-4. PubMed ID: 25897550
[No Abstract] [Full Text] [Related]
3. Anoro Ellipta: an inhaled umeclidinium/vilanterol combination for COPD.
Med Lett Drugs Ther; 2014 Apr; 56(1440):30-1. PubMed ID: 24736248
[No Abstract] [Full Text] [Related]
4. Table: Correct Use of inhalers for COPD.
Med Lett Drugs Ther; 2020 Sep; 62(1606):e150-e154. PubMed ID: 32960876
[No Abstract] [Full Text] [Related]
5. ▼Umeclidinium: another LAMA for COPD.
Drug Ther Bull; 2015 Jul; 53(7):81-4. PubMed ID: 26159701
[TBL] [Abstract][Full Text] [Related]
6. Umeclidinium bromide and vilanterol in combination for the treatment of chronic obstructive pulmonary disease.
Kelly E
Expert Rev Clin Pharmacol; 2014 Jul; 7(4):403-13. PubMed ID: 24909949
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in chronic obstructive pulmonary disease: results of a 24-week, randomized, controlled trial.
Maleki-Yazdi MR; Kaelin T; Richard N; Zvarich M; Church A
Respir Med; 2014 Dec; 108(12):1752-60. PubMed ID: 25458157
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD.
Donohue JF; Maleki-Yazdi MR; Kilbride S; Mehta R; Kalberg C; Church A
Respir Med; 2013 Oct; 107(10):1538-46. PubMed ID: 23830094
[TBL] [Abstract][Full Text] [Related]
9. [Combinations of bronchodilators in COPD therapy--"fashionable" or rule?].
Mihălţan F
Pneumologia; 2013; 62(3):172-5. PubMed ID: 24274002
[TBL] [Abstract][Full Text] [Related]
10. Umeclidinium/vilanterol fixed-dose combination for COPD.
Gras J
Drugs Today (Barc); 2014 Mar; 50(3):231-8. PubMed ID: 24696868
[TBL] [Abstract][Full Text] [Related]
11. Magnitude of umeclidinium/vilanterol lung function effect depends on monotherapy responses: Results from two randomised controlled trials.
Donohue JF; Singh D; Munzu C; Kilbride S; Church A
Respir Med; 2016 Mar; 112():65-74. PubMed ID: 26797016
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials.
Decramer M; Anzueto A; Kerwin E; Kaelin T; Richard N; Crater G; Tabberer M; Harris S; Church A
Lancet Respir Med; 2014 Jun; 2(6):472-86. PubMed ID: 24835833
[TBL] [Abstract][Full Text] [Related]
13. [COPD treatment by drugs].
Nafti S
Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S58-10S60. PubMed ID: 17127967
[No Abstract] [Full Text] [Related]
14. Umeclidinium for the treatment of chronic obstructive pulmonary disease.
Segreti A; Calzetta L; Rogliani P; Cazzola M
Expert Rev Respir Med; 2014 Dec; 8(6):665-71. PubMed ID: 25312239
[TBL] [Abstract][Full Text] [Related]
15. [Medical treatment of COPD].
Vestbo J; Titlestad IL
Ugeskr Laeger; 2013 Apr; 175(18):1261-4. PubMed ID: 23651802
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
[TBL] [Abstract][Full Text] [Related]
17. [Current optimization of combined therapy for chronic obstructive pulmonary disease].
Popova EN
Ter Arkh; 2015; 87(12):107-110. PubMed ID: 27022659
[TBL] [Abstract][Full Text] [Related]
18. Revefenacin (Yupelri) for COPD.
Med Lett Drugs Ther; 2019 Jan; 61(1564):14-15. PubMed ID: 30856160
[No Abstract] [Full Text] [Related]
19. Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials.
Riley JH; Tabberer M; Richard N; Donald A; Church A; Harris SS
Int J Chron Obstruct Pulmon Dis; 2016; 11():1873-80. PubMed ID: 27578968
[TBL] [Abstract][Full Text] [Related]
20. Umeclidinium for treating COPD: an evaluation of pharmacologic properties, safety and clinical use.
Manickam R; Asija A; Aronow WS
Expert Opin Drug Saf; 2014 Nov; 13(11):1555-61. PubMed ID: 25294427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
